These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 8039976

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
    Harvima IT, Haapanen L, Ackermann L, Naukkarinen A, Harvima RJ, Horsmanheimo M.
    Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin.
    Naukkarinen A, Järvikallio A, Lakkakorpi J, Harvima IT, Harvima RJ, Horsmanheimo M.
    J Pathol; 1996 Oct; 180(2):200-5. PubMed ID: 8976881
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
    Caughey GH, Leidig F, Viro NF, Nadel JA.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R, Harvima IT, Naukkarinen A, Nilsson G, Horsmanheimo M.
    J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
    Kivinen PK, Kaminska R, Naukkarinen A, Harvima RJ, Horsmanheimo M, Harvima IT.
    Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
    [Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema.
    Järvikallio A, Naukkarinen A, Harvima IT, Aalto ML, Horsmanheimo M.
    Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819
    [Abstract] [Full Text] [Related]

  • 16. Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.
    Gulubova MV.
    Clin Exp Metastasis; 2003 Jun; 20(7):611-20. PubMed ID: 14669792
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions.
    Kankkunen JP, Harvima IT, Naukkarinen A.
    Int J Cancer; 1997 Jul 29; 72(3):385-8. PubMed ID: 9247277
    [Abstract] [Full Text] [Related]

  • 18. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M, Harvima IT.
    Br J Dermatol; 2005 Jun 29; 152(6):1149-60. PubMed ID: 15948975
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis.
    Badertscher K, Brönnimann M, Karlen S, Braathen LR, Yawalkar N.
    Arch Dermatol Res; 2005 Apr 29; 296(10):503-6. PubMed ID: 15703960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.